Terms: = Germ cell tumor AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Clinical Outcome
14 results:
1. Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab.
Manneh Kopp RA; Sepúlveda-Sánchez JM; Ruano Y; Toldos O; Pérez Núñez A; Cantero D; Hilario A; Ramos A; de Velasco G; Sánchez-Gómez P; Hernández-Laín A
Clin Transl Oncol; 2019 Oct; 21(10):1413-1423. PubMed ID: 30877636
[TBL] [Abstract] [Full Text] [Related]
2. Spontaneous intracerebral hemorrhage as presentation of atypical central neurocytoma: the role of angiogenesis through the characterization of tumor endothelial cells.
Marfia G; Pirola E; Navone SE; Beretta M; Guarnaccia L; Trombetta E; Franzini A; Rampini P; Campanella R
Histol Histopathol; 2018 Jul; 33(7):665-672. PubMed ID: 29215136
[TBL] [Abstract] [Full Text] [Related]
3. Autophagy-induced kdr/vegfr-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells.
Wu HB; Yang S; Weng HY; Chen Q; Zhao XL; Fu WJ; Niu Q; Ping YF; Wang JM; Zhang X; Yao XH; Bian XW
Autophagy; 2017 Sep; 13(9):1528-1542. PubMed ID: 28812437
[TBL] [Abstract] [Full Text] [Related]
4. Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours.
Zurita AJ; Khajavi M; Wu HK; Tye L; Huang X; Kulke MH; Lenz HJ; Meropol NJ; Carley W; DePrimo SE; Lin E; Wang X; Harmon CS; Heymach JV
Br J Cancer; 2015 Mar; 112(7):1199-205. PubMed ID: 25756398
[TBL] [Abstract] [Full Text] [Related]
5. Correlation of somatic mutations and clinical outcome in melanoma patients treated with Carboplatin, Paclitaxel, and sorafenib.
Wilson MA; Zhao F; Letrero R; D'Andrea K; Rimm DL; Kirkwood JM; Kluger HM; Lee SJ; Schuchter LM; Flaherty KT; Nathanson KL
Clin Cancer Res; 2014 Jun; 20(12):3328-37. PubMed ID: 24714776
[TBL] [Abstract] [Full Text] [Related]
6. Distinct phenotypic differences associated with differential amplification of receptor tyrosine kinase genes at 4q12 in glioblastoma.
Burford A; Little SE; Jury A; Popov S; Laxton R; Doey L; Al-Sarraj S; Jürgensmeier JM; Jones C
PLoS One; 2013; 8(8):e71777. PubMed ID: 23990986
[TBL] [Abstract] [Full Text] [Related]
7. Role of platelet derived growth factor receptor (PDGFR) over-expression and angiogenesis in ependymoma.
Moreno L; Popov S; Jury A; Al Sarraj S; Jones C; Zacharoulis S
J Neurooncol; 2013 Jan; 111(2):169-76. PubMed ID: 23135775
[TBL] [Abstract] [Full Text] [Related]
8. Vandetanib: in medullary thyroid cancer.
Frampton JE
Drugs; 2012 Jul; 72(10):1423-36. PubMed ID: 22715896
[TBL] [Abstract] [Full Text] [Related]
9. Phosphorylated pvegfr2/kdr receptor expression in uveal melanomas: relation with HIF2α and survival.
Giatromanolaki A; Sivridis E; Bechrakis NE; Willerding G; St Charitoudis G; Foerster MH; Gatter KC; Harris AL; Koukourakis MI
Clin Exp Metastasis; 2012 Jan; 29(1):11-7. PubMed ID: 21984395
[TBL] [Abstract] [Full Text] [Related]
10. Neural stem cell tropism to glioma: critical role of tumor hypoxia.
Zhao D; Najbauer J; Garcia E; Metz MZ; Gutova M; Glackin CA; Kim SU; Aboody KS
Mol Cancer Res; 2008 Dec; 6(12):1819-29. PubMed ID: 19074827
[TBL] [Abstract] [Full Text] [Related]
11. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
Brychtova S; Bezdekova M; Brychta T; Tichy M
Neoplasma; 2008; 55(4):273-9. PubMed ID: 18505336
[TBL] [Abstract] [Full Text] [Related]
12. Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases.
Lee L; Sharma S; Morgan B; Allegrini P; Schnell C; Brueggen J; Cozens R; Horsfield M; Guenther C; Steward WP; Drevs J; Lebwohl D; Wood J; McSheehy PM
Cancer Chemother Pharmacol; 2006 Jun; 57(6):761-71. PubMed ID: 16172907
[TBL] [Abstract] [Full Text] [Related]
13. Angiogenesis and vascular growth factor receptor expression in malignant melanoma.
Lin EY; Piepkorn M; Garcia R; Byrd D; Tsou R; Isik FF
Plast Reconstr Surg; 1999 Nov; 104(6):1666-74. PubMed ID: 10541167
[TBL] [Abstract] [Full Text] [Related]
14. Vascular endothelial growth factor expression in human neuroblastoma: up-regulation by hypoxia.
Rössler J; Breit S; Havers W; Schweigerer L
Int J Cancer; 1999 Mar; 81(1):113-7. PubMed ID: 10077161
[TBL] [Abstract] [Full Text] [Related]
